| 新型抗心绞痛药物雷诺嗪研究进展 |
| |
| 引用本文： | 王焕章,程远国,刘学龙.新型抗心绞痛药物雷诺嗪研究进展[J].动物医学进展,2008,29(11). |
| |
| 作者姓名： | 王焕章 程远国 刘学龙 |
| |
| 作者单位： | 1. 延边大学农学院,吉林龙井,133400
2. 军事医学科学院微生物流行病研究所,北京,100071 |
| |
| 摘 要： | 心肌缺血通常导致一系列的代谢变化，通过改善缺血心肌的代谢和心肌功能，可治疗缺血性心脏病。论文对代谢性治疗药物雷诺嗪抗心绞痛的作用机制及临床应用进行综述。
|
| 关 键 词： | 心肌缺血 心肌代谢 代谢性治疗药物 雷诺嗪 心绞痛 |
Progress on A Novel Antianginal Agent Ranolazine |
| |
| WANG Huan-zhang,CHENG Yuan-guo,LIU Xue-long.Progress on A Novel Antianginal Agent Ranolazine[J].Progress In Veterinary Medicine,2008,29(11). |
| |
| Authors: | WANG Huan-zhang CHENG Yuan-guo LIU Xue-long |
| |
| Institution: | 1.Agronomy Academy;Yanbian University;Longjing;Jilin;133400;China;2.Institute of Microbiology and Epidemiology;Academy of Military Medical Science;Beijing;100071;China |
| |
| Abstract: | Myocardial ischemia often leads to a series of metabolic changes.Metabolic management of myocardial ischemia may improve myocardial functions.Therefore,metabolic intervention is a valid approach to the treatment of ischemic heart diseases.The effects of an antianginal metabolic agent and their mechanisms of action and clinical application were discussed here. |
| |
| Keywords: | myocardial ischemia myocardial metabolism metabolic agent ranolazine angina |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
